Story thread · 2 reports / 1 sources
Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target
financialpost.com · 2h
TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today […]
First report: Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto — financialpost.com, 2d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.